Monografie
Immunotherapy of pediatric acute lymphoblastic B-cell leukemia using gene-modified T cells
- Language
-
Englisch
- Identifier
-
124475479X
- Subject
-
Leukemia; Immunotherapy; T cells
- Contributor
-
Blaeschke, Franziska
Feuchtinger, Tobias
- DOI
-
10.5282/edoc.28644
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
26.01.2023, 1:56 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Monografie
Associated
- Blaeschke, Franziska
- Feuchtinger, Tobias
Other Objects (12)
The clinical relevance of aneuploidy in relapses of pediatric B-cell precursor acute lymphoblastic leukemia
Prognostic impact of leukemia biology in pediatric acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Restoration of mutant TP53 as a therapeutic targeting strategy in pediatric B-cell precursor acute lymphoblastic leukemia
Biomarker profile for prediction of response to SMAC mimetic monotherapy in pediatric precursor B‐cell acute lymphoblastic leukemia
On the hunt for B-cell lymphoblastic leukemia-initiating stem cells
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
Genetic and Epigenetic Landscapes of Pediatric Acute Lymphoblastic Leukemia Subtypes
Acute lymphoblastic leukemia
LncRNAs signature defining major subtypes of B-cell acute lymphoblastic leukemia
Role of microRNA-497~195 in pediatric acute lymphoblastic leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
The clinical relevance of aneuploidy in relapses of pediatric B-cell precursor acute lymphoblastic leukemia
Prognostic impact of leukemia biology in pediatric acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Restoration of mutant TP53 as a therapeutic targeting strategy in pediatric B-cell precursor acute lymphoblastic leukemia
Biomarker profile for prediction of response to SMAC mimetic monotherapy in pediatric precursor B‐cell acute lymphoblastic leukemia
On the hunt for B-cell lymphoblastic leukemia-initiating stem cells
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
Genetic and Epigenetic Landscapes of Pediatric Acute Lymphoblastic Leukemia Subtypes
Acute lymphoblastic leukemia
LncRNAs signature defining major subtypes of B-cell acute lymphoblastic leukemia
Role of microRNA-497~195 in pediatric acute lymphoblastic leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
The clinical relevance of aneuploidy in relapses of pediatric B-cell precursor acute lymphoblastic leukemia
Prognostic impact of leukemia biology in pediatric acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Restoration of mutant TP53 as a therapeutic targeting strategy in pediatric B-cell precursor acute lymphoblastic leukemia
Biomarker profile for prediction of response to SMAC mimetic monotherapy in pediatric precursor B‐cell acute lymphoblastic leukemia
On the hunt for B-cell lymphoblastic leukemia-initiating stem cells
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
Genetic and Epigenetic Landscapes of Pediatric Acute Lymphoblastic Leukemia Subtypes
Acute lymphoblastic leukemia
LncRNAs signature defining major subtypes of B-cell acute lymphoblastic leukemia
Role of microRNA-497~195 in pediatric acute lymphoblastic leukemia